Incorrect storage of drug; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 3-year-old patient who received Hib (Hiberix) (batch number 7AC3C, expiry date SEP-2025) for prophylaxis. Co-suspect products included HAV (Havrix) (batch number TF27T, expiry date FEB-2026) for prophylaxis. Previously administered products included Hiberix (Received first dose on unknown date), Hiberix (Received second dose on unknown date) and Hiberix (Received third dose on unknown date). Additional patient notes included Ethnicity. On 19-AUG-2024, the patient received the 4th dose of Hiberix (intramuscular, left thigh) and the 1st dose of Havrix (intramuscular, right thigh). On an unknown date, an unknown time after receiving Hiberix and Havrix, the patient experienced incorrect storage of drug (Verbatim: Incorrect storage of drug). The outcome of the incorrect storage of drug was unknown. Additional Information: GSK receipt date: 02-DEC-2024 The patient received Hiberixand Havrix vaccine after temperature excursion, which led to incorrect storage of drug. This was 1 of 17 linked report, reported by same reporter.; Sender’s Comments: US-GSK-US2024AMR153916:Original Case : US2024AMR153742 US-GSK-US2024AMR153917:Original Case : US2024AMR153742 US-GSK-US2024AMR153918:Original Case : US2024AMR153742 US-GSK-US2024AMR153919:Original Case : US2024AMR153742 US-GSK-US2024AMR153920:Original Case : US2024AMR153742 US-GSK-US2024AMR153921:Original Case : US2024AMR153742 US-GSK-US2024AMR153929:Original Case : US2024AMR153742 US-GSK-US2024AMR153923:Original Case : US2024AMR153742 US-GSK-US2024AMR153742:Original Case : US2024AMR153742 US-GSK-US2024AMR153925:Original Case : US2024AMR153742 US-GSK-US2024AMR153926:Original Case : US2024AMR153742 US-GSK-US2024AMR153927:Original Case : US2024AMR153742 US-GSK-US2024AMR153928:Original Case : US2024AMR153742 US-GSK-US2024AMR153922:Original Case : US2024AMR153742 US-GSK-US2024123268:Same reporter US-GSK-US2024123266:Same reporter